Share
News

UK Scientists Report Smooth Sailing for COVID Vaccine Trial

Share

Scientists at Imperial College London say they are immunizing hundreds of people with an experimental coronavirus vaccine in an early trial after seeing no problems in a small number vaccinated so far.

Dr. Robin Shattock, a professor at the college, told The Associated Press that he and colleagues had just finished the very slow and arduous process of testing the vaccine at a low dose in initial participants and would now expand the trial to about 300 people, including some over age 75.

“It’s well tolerated. There aren’t any side effects,” he said, adding it was still very early in the study.

Shattock, who is leading the vaccine research at Imperial, said he hopes to have enough safety data to start inoculating several thousand people in October.

Since COVID-19 infections have dropped dramatically in Britain, making it difficult to determine whether or not the vaccine works, Shattock said he and his colleagues are also looking to test their vaccine elsewhere.

Trending:
Obama-Appointed Judge Holds Former Fox News Reporter Catherine Herridge in Contempt for Refusing to Reveal Her Sources

“We’re looking very carefully at the pandemic, at the numbers where the hot spots are and talking to collaborators that have the facilities to do these kinds of studies,” he said.

The Imperial vaccine uses synthetic strands of genetic code based on the virus. Once injected into a muscle, the body’s own cells are instructed to make copies of a spiky protein on the coronavirus.

That should in turn trigger an immune response so the body can fight off any future COVID-19 infection.

Earlier this week, the world’s biggest coronavirus vaccine study started in the United States, with the first of 30,000 planned volunteers getting immunized with shots created by the U.S. National Institutes of Health and Moderna Inc.

Do you believe a vaccine will be available soon?

Several other vaccines made by China and by Britain’s Oxford University, based on different vaccine technologies, began smaller final-stage tests in Brazil and other hard-hit countries earlier this month.

The World Health Organization has said multiple vaccine approaches are necessary for COVID-19, noting that the usual success rate for vaccine development is about 10 percent.

Shattock said there were numerous coronavirus vaccines now in clinical trials, and he predicted that at least some of them would prove to be effective.

“We have 20 vaccines in clinical trials, [so] we can be pretty confident that at least two of those will work,” he said.

“It really depends on how strong the immune response needs to be to provide protection.”

Related:
Watch: Tucker Carlson Says Election '100% Stolen' from Trump, Breaks Down How it Happened

Shattock said he was optimistic the Imperial vaccine would work, but must await the data from the trial.

“I’m just going to hold my breath and wait to see,” he said.


[jwplayer jjQQVZiQ]

The Western Journal has reviewed this Associated Press story and may have altered it prior to publication to ensure that it meets our editorial standards.

Truth and Accuracy

Submit a Correction →



We are committed to truth and accuracy in all of our journalism. Read our editorial standards.

Tags:
, , , , , ,
Share
The Associated Press is an independent, not-for-profit news cooperative headquartered in New York City. Their teams in over 100 countries tell the world’s stories, from breaking news to investigative reporting. They provide content and services to help engage audiences worldwide, working with companies of all types, from broadcasters to brands. Photo credit: @AP on Twitter
The Associated Press was the first private sector organization in the U.S. to operate on a national scale. Over the past 170 years, they have been first to inform the world of many of history's most important moments, from the assassination of Abraham Lincoln and the bombing of Pearl Harbor to the fall of the Shah of Iran and the death of Pope John Paul.

Today, they operate in 263 locations in more than 100 countries relaying breaking news, covering war and conflict and producing enterprise reports that tell the world's stories.
Location
New York City




Conversation